Novavax's Ebola vaccine shows promise in early-stage trial

(Reuters) - Novavax Inc said its experimental Ebola vaccine induced a substantial immune response to the deadly infection in an early-stage trial involving 230 healthy adults.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news